MOG and myeloid sarcoma: Here we employed proteome profiling of MOG-EAE and the ciliary neurotrophic factor knockout mouse (CNTF −/− mouse) as model with enhanced tissue injury including axonal degeneration and oligodendrocyte (OL) apoptosis to screen for disease regulated proteins which could serve as candidate biomarkers in MS patients.